Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study

Objective A growing body of evidence points to a role for herpesviruses in the development of Alzheimer’s disease (AD) and a reduced risk of AD among patients receiving antiherpetic medications. We investigated the association between herpes simplex virus type 1 (HSV-1) and AD using real-world data...

Full description

Saved in:
Bibliographic Details
Main Authors: Christine Johnston, Simon P Fletcher, Yunhao Liu, Shahed Iqbal, Nadine Jarousse
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e093946.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128628763852800
author Christine Johnston
Simon P Fletcher
Yunhao Liu
Shahed Iqbal
Nadine Jarousse
author_facet Christine Johnston
Simon P Fletcher
Yunhao Liu
Shahed Iqbal
Nadine Jarousse
author_sort Christine Johnston
collection DOAJ
description Objective A growing body of evidence points to a role for herpesviruses in the development of Alzheimer’s disease (AD) and a reduced risk of AD among patients receiving antiherpetic medications. We investigated the association between herpes simplex virus type 1 (HSV-1) and AD using real-world data (RWD) from USA.Design In a matched case–control study, patients with AD aged ≥50 years diagnosed between 2006 and 2021 were identified from the IQVIA PharMetrics Plus claims database. Controls were matched in a 1:1 ratio with subjects with AD on age, sex, region, database entry year and healthcare visit numbers.Results The study included 344 628 AD case–control pairs. History of HSV-1 diagnosis was present in 1507 (0.44%) patients with AD compared with 823 (0.24%) controls. HSV-1 diagnosis was found to be associated with AD (adjusted OR 1.80; 95% CI 1.65 to 1.96). Patients with HSV-1 who used antiherpetics were less likely to develop AD compared with those who did not use antiherpetics (adjusted HR 0.83, 95% CI 0.74 to 0.92).Conclusions Findings from this large RWD study implicate HSV-1 in the development of AD and highlight antiherpetic therapies as potentially protective for AD and related dementia.
format Article
id doaj-art-6bbf0cd2f6ef424f850f954fbd4798b1
institution OA Journals
issn 2044-6055
language English
publishDate 2025-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-6bbf0cd2f6ef424f850f954fbd4798b12025-08-20T02:33:14ZengBMJ Publishing GroupBMJ Open2044-60552025-05-0115510.1136/bmjopen-2024-093946Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control studyChristine Johnston0Simon P Fletcher1Yunhao Liu2Shahed Iqbal3Nadine Jarousse42 Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA1 Gilead Sciences Inc, Foster City, California, USA1 Gilead Sciences Inc, Foster City, California, USA1 Gilead Sciences Inc, Foster City, California, USA1 Gilead Sciences Inc, Foster City, California, USAObjective A growing body of evidence points to a role for herpesviruses in the development of Alzheimer’s disease (AD) and a reduced risk of AD among patients receiving antiherpetic medications. We investigated the association between herpes simplex virus type 1 (HSV-1) and AD using real-world data (RWD) from USA.Design In a matched case–control study, patients with AD aged ≥50 years diagnosed between 2006 and 2021 were identified from the IQVIA PharMetrics Plus claims database. Controls were matched in a 1:1 ratio with subjects with AD on age, sex, region, database entry year and healthcare visit numbers.Results The study included 344 628 AD case–control pairs. History of HSV-1 diagnosis was present in 1507 (0.44%) patients with AD compared with 823 (0.24%) controls. HSV-1 diagnosis was found to be associated with AD (adjusted OR 1.80; 95% CI 1.65 to 1.96). Patients with HSV-1 who used antiherpetics were less likely to develop AD compared with those who did not use antiherpetics (adjusted HR 0.83, 95% CI 0.74 to 0.92).Conclusions Findings from this large RWD study implicate HSV-1 in the development of AD and highlight antiherpetic therapies as potentially protective for AD and related dementia.https://bmjopen.bmj.com/content/15/5/e093946.full
spellingShingle Christine Johnston
Simon P Fletcher
Yunhao Liu
Shahed Iqbal
Nadine Jarousse
Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study
BMJ Open
title Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study
title_full Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study
title_fullStr Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study
title_full_unstemmed Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study
title_short Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study
title_sort association between herpes simplex virus type 1 and the risk of alzheimer s disease a retrospective case control study
url https://bmjopen.bmj.com/content/15/5/e093946.full
work_keys_str_mv AT christinejohnston associationbetweenherpessimplexvirustype1andtheriskofalzheimersdiseasearetrospectivecasecontrolstudy
AT simonpfletcher associationbetweenherpessimplexvirustype1andtheriskofalzheimersdiseasearetrospectivecasecontrolstudy
AT yunhaoliu associationbetweenherpessimplexvirustype1andtheriskofalzheimersdiseasearetrospectivecasecontrolstudy
AT shahediqbal associationbetweenherpessimplexvirustype1andtheriskofalzheimersdiseasearetrospectivecasecontrolstudy
AT nadinejarousse associationbetweenherpessimplexvirustype1andtheriskofalzheimersdiseasearetrospectivecasecontrolstudy